IMMUNEID

immuneid-logo

ImmuneID is a precision immunology company using its proprietary platform to simultaneously identify and therapeutically target millions of antibody interactions that drive immune diseases.

#SimilarOrganizations #People #Financial #Event #Website #More

IMMUNEID

Social Links:

Industry:
Biotechnology Health Care Therapeutics

Founded:
2020-01-01

Address:
Boston, Massachusetts, United States

Country:
United States

Website Url:
http://www.immuneidrx.com

Total Employee:
1+

Status:
Active

Total Funding:
67 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome


Similar Organizations

arkuda-therapeutics-logo

Arkuda Therapeutics

Arkuda Therapeutics is a pharmaceutical company.

calimmune-logo

Calimmune

Calimmune is a clinical-stage gene therapy company.

emendo-biotherapeutics-logo

Emendo Biotherapeutics

Emendo Biotherapeutics is a biotechnology company

rain-therapeutics-logo

Rain Therapeutics

Rain Therapeutics is a operator of a clinical stage biotechnology company.


Current Advisors List

steven-j-kafka_image

Steven J. Kafka Board Member @ ImmuneID
Board_member

dan-janney_image

Dan Janney Board of Director @ ImmuneID
Board_member

Current Employees Featured

james-s-scibetta_image

James S. Scibetta
James S. Scibetta Chief Executive Officer @ ImmuneID
Chief Executive Officer
2021-09-01

annalisa-dandrea_image

Annalisa Dโ€™Andrea
Annalisa Dโ€™Andrea President & Chief Scientific Officer @ ImmuneID
President & Chief Scientific Officer
2021-04-01

christoph-westphal_image

Christoph Westphal
Christoph Westphal Co-Founder, Chairman & Board Member @ ImmuneID
Co-Founder, Chairman & Board Member

lea-hachigian_image

Lea Hachigian
Lea Hachigian Co-Founder, Chief Executive Officer & Board Member @ ImmuneID
Co-Founder, Chief Executive Officer & Board Member
2020-12-01

not_available_image

Jeremiah Degenhardt
Jeremiah Degenhardt SVP Computational Biology @ ImmuneID
SVP Computational Biology
2022-01-01

Founder


christoph-westphal_image

Christoph Westphal

lea-hachigian_image

Lea Hachigian

Investors List

xfund_image

Xfund

Xfund investment in Series A - ImmuneID

alta-partners_image

Alta Partners

Alta Partners investment in Series A - ImmuneID

in-q-tel_image

In-Q-Tel

In-Q-Tel investment in Series A - ImmuneID

section-32_image

Section 32

Section 32 investment in Series A - ImmuneID

redwood-capital-investments_image

Redwood Capital Investments

Redwood Capital Investments investment in Series A - ImmuneID

alexandria-venture-investments_image

Alexandria Venture Investments

Alexandria Venture Investments investment in Series A - ImmuneID

longwood-founders-fund_image

Longwood Fund

Longwood Fund investment in Series A - ImmuneID

arch-venture-partners_image

ARCH Venture Partners

ARCH Venture Partners investment in Series A - ImmuneID

tekla-capital-management_image

Tekla Capital Management

Tekla Capital Management investment in Series A - ImmuneID

pitango-venture-capital_image

Pitango Venture Capital

Pitango Venture Capital investment in Venture Round - ImmuneID

Official Site Inspections

http://www.immuneidrx.com Semrush global rank: 4.36 M Semrush visits lastest month: 2.59 K

  • Host name: 104.21.57.74
  • IP address: 104.21.57.74
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "ImmuneID"

ImmuneID - Crunchbase Company Profile & Funding

Contact Email [email protected] ImmuneID is a precision immunology company using its proprietary platform to simultaneously identify and therapeutically target millions of antibody โ€ฆSee details»

ImmuneID 2025 Company Profile: Valuation, Funding โ€ฆ

Information on valuation, funding, cap tables, investors, and executives for ImmuneID. Use the PitchBook Platform to explore the full profile.See details»

ImmuneID Company Profile | Management and Employees List

[email protected]: 6: first + last: [email protected]: 7: first_last: [email protected]: Your Questions, Our Answers Get Free Access to ImmuneID โ€ฆSee details»

ImmuneID - Overview, News & Similar companies | ZoomInfo.com

Oct 17, 2022 View ImmuneID (www.immuneidrx.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as well as employees โ€ฆSee details»

ImmuneID - Products, Competitors, Financials, Employees, โ€ฆ

Headquarters Location. 275 Second Avenue Suite 100. Waltham, Massachusetts, 02451, United States. 617-935-7092See details»

ImmuneID - VentureRadar

"ImmuneID is a precision immunology company using its proprietary platform to simultaneously identify and therapeutically target millions of antibody interactions that drive immune diseases.See details»

IMMUNEID, INC. Company Profile | Waltham, MA - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for IMMUNEID, INC. of Waltham, MA. Get the latest business insights from Dun & Bradstreet.See details»

ImmuneID Appoints Veteran Biotech Executive James โ€ฆ

Sep 21, 2021 Founded in late 2020 by Longwood Fund, ImmuneID is headquartered in Cambridge, MA. For more information, visit www.immuneidrx.com. Contacts.See details»

ImmuneIDโ€™s Competitors, Revenue, Number of Employees, โ€ฆ

ImmuneIDโ€™s Profile, Revenue and Employees. ImmuneID is a Massachusetts-based precision immunology company that develops a proprietary platform to identify and treat autoimmune โ€ฆSee details»

Immuneid Company Profile -Sales, Contacts, Competitors โ€“ Buzzfile

Immuneid is in the Management Consulting Services industry within the Engineering, Accounting, Research, and Management Services sector and has been in business for approximately 5 years.See details»

ImmuneID, Inc. - Drug pipelines, Patents, Clinical trials - Synapse

Explore ImmuneID, Inc. with its drug pipeline, therapeutic area, technology platform, 10 news.See details»

ImmuneID Launches with $17M Financing to Profile and Modulate โ€ฆ

Feb 17, 2021 Media Rob Kloppenburg [email protected] 617-930-5595 Contacts. Media Rob Kloppenburg [email protected] 617-930-5595 Site Navigation. Home. Home; โ€ฆSee details»

ImmuneID Announces Close of $50 Million Series A Financing to โ€ฆ

Jun 23, 2021 Longwood Fund-founded company has raised over $70 million since its Q4 2020 launch. Proprietary platform licensed from Dr. Stephen Elledgeโ€™s laboratory used to develop โ€ฆSee details»

ImmuneID Announces Appointment of Pam Stetkiewicz, Ph.D., to โ€ฆ

Jul 12, 2022 In addition, Dr. Stetkiewicz served as Vice President, Program and Alliance Management at Editas Medicine, where she was responsible for building the development โ€ฆSee details»

ImmuneID Launches with $17M Financing to Profile and

Feb 17, 2021 ImmuneID, Inc., a precision immunology company employing a proprietary platform to identify and therapeutically target antibody interactions that drive immune diseases, โ€ฆSee details»

ImmuneID Announces Key Partnerships with Icahn School of โ€ฆ

Mar 31, 2022 Partners to Provide Unique Expertise and Resources into Immune System Exposure, Patient Segmentation, and Target Identification. WALTHAM, Mass., March 31, โ€ฆSee details»

ImmuneID | VentureRadar

ImmuneID is a precision immunology company using its proprietary platform to simultaneously identify and therapeutically target millions of antibody... ... Find out ...See details»

ImmuneID Appoints Jessica Atkinson as Chief Business Officer - PR โ€ฆ

Oct 17, 2022 ImmuneID is a biopharmaceutical company dedicated to rapidly illuminating and untangling the complexities of the immune system leading to precise, transformative therapies โ€ฆSee details»

ImmuneID Appoints Veteran Biotech Executive James S ... - BioSpace

Sep 21, 2021 CAMBRIDGE, Mass.--(BUSINESS WIRE)-- ImmuneID, Inc., a precision immunology company employing a proprietary platform to identify and therapeutically target โ€ฆSee details»

ARCH-backed ImmuneID restructures and searches for partners

Jul 19, 2023 Boston-area biotech ImmuneID has gone through a recent restructuring and is searching for partners on its platform, which was born out of the same Harvard lab as TScan โ€ฆSee details»

linkstock.net © 2022. All rights reserved